Cargando…
Inhibition of Tumor Growth via Systemic siRNA Delivery Using Reducible Bile Acid-Conjugated Polyethylenimine
RNA interference (RNAi), mediated by small interfering RNA (siRNA), has been considered as a potential therapeutic agent for cancer owing to its ability to suppress target genes in a sequence-specific manner. In this study, a conjugate of the low molecular weight (M(W)) polyethylenimine (PEI) (M(W)...
Autores principales: | Yin, Yue, Lee, Jung Eun, Kim, Nak Won, Lee, Jong Han, Lim, Su Yeon, Kim, E Seul, Park, Ji Won, Lee, Min Sang, Jeong, Ji Hoon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6403700/ https://www.ncbi.nlm.nih.gov/pubmed/30960878 http://dx.doi.org/10.3390/polym10090953 |
Ejemplares similares
-
Polyethylenimine-Conjugated Hydroxyethyl Cellulose for Doxorubicin/Bcl-2 siRNA Co-Delivery Systems
por: Park, Jiwon, et al.
Publicado: (2023) -
Cyclodextrin and Polyethylenimine Functionalized Mesoporous Silica Nanoparticles for Delivery of siRNA Cancer Therapeutics
por: Shen, Jianliang, et al.
Publicado: (2014) -
cRGD peptide-conjugated polyethylenimine-based lipid nanoparticle for intracellular delivery of siRNA in hepatocarcinoma therapy
por: Yang, Shuang, et al.
Publicado: (2021) -
Integration of Polylactide into Polyethylenimine Facilitates the Safe and Effective Intracellular siRNA Delivery
por: Ding, Guo-Bin, et al.
Publicado: (2020) -
Hydroxyethyl substituted linear polyethylenimine for safe and efficient delivery of siRNA therapeutics
por: Patil, Sushilkumar, et al.
Publicado: (2018)